nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyldopa—hypertension—metabolic syndrome X	0.962	1	CtDrD
Methyldopa—Distention—Metformin—metabolic syndrome X	0.00698	0.216	CcSEcCtD
Methyldopa—Lightheadedness—Metformin—metabolic syndrome X	0.00147	0.0455	CcSEcCtD
Methyldopa—Nasal congestion—Metformin—metabolic syndrome X	0.00131	0.0405	CcSEcCtD
Methyldopa—Liver function test abnormal—Metformin—metabolic syndrome X	0.0011	0.034	CcSEcCtD
Methyldopa—Breast disorder—Metformin—metabolic syndrome X	0.00108	0.0333	CcSEcCtD
Methyldopa—Abdominal distension—Metformin—metabolic syndrome X	0.00104	0.0321	CcSEcCtD
Methyldopa—Pancreatitis—Metformin—metabolic syndrome X	0.00101	0.0312	CcSEcCtD
Methyldopa—Angina pectoris—Metformin—metabolic syndrome X	0.001	0.031	CcSEcCtD
Methyldopa—Infestation NOS—Metformin—metabolic syndrome X	0.00092	0.0284	CcSEcCtD
Methyldopa—Infestation—Metformin—metabolic syndrome X	0.00092	0.0284	CcSEcCtD
Methyldopa—Hepatobiliary disease—Metformin—metabolic syndrome X	0.00087	0.0269	CcSEcCtD
Methyldopa—Bradycardia—Metformin—metabolic syndrome X	0.000841	0.026	CcSEcCtD
Methyldopa—Hepatitis—Metformin—metabolic syndrome X	0.000826	0.0255	CcSEcCtD
Methyldopa—Mesalazine—PPARG—metabolic syndrome X	0.000817	0.405	CrCbGaD
Methyldopa—Connective tissue disorder—Metformin—metabolic syndrome X	0.000811	0.0251	CcSEcCtD
Methyldopa—Cardiac disorder—Metformin—metabolic syndrome X	0.000766	0.0237	CcSEcCtD
Methyldopa—Angiopathy—Metformin—metabolic syndrome X	0.000749	0.0231	CcSEcCtD
Methyldopa—Mediastinal disorder—Metformin—metabolic syndrome X	0.000744	0.023	CcSEcCtD
Methyldopa—Flatulence—Metformin—metabolic syndrome X	0.000708	0.0219	CcSEcCtD
Methyldopa—Myalgia—Metformin—metabolic syndrome X	0.000612	0.0189	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000608	0.0188	CcSEcCtD
Methyldopa—Oedema—Metformin—metabolic syndrome X	0.000587	0.0181	CcSEcCtD
Methyldopa—Infection—Metformin—metabolic syndrome X	0.000583	0.018	CcSEcCtD
Methyldopa—Nervous system disorder—Metformin—metabolic syndrome X	0.000575	0.0178	CcSEcCtD
Methyldopa—Thrombocytopenia—Metformin—metabolic syndrome X	0.000574	0.0177	CcSEcCtD
Methyldopa—Skin disorder—Metformin—metabolic syndrome X	0.00057	0.0176	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000534	0.0165	CcSEcCtD
Methyldopa—Paraesthesia—Metformin—metabolic syndrome X	0.000527	0.0163	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000506	0.0156	CcSEcCtD
Methyldopa—Constipation—Metformin—metabolic syndrome X	0.000502	0.0155	CcSEcCtD
Methyldopa—Aminosalicylic Acid—PTGS2—metabolic syndrome X	0.00044	0.218	CrCbGaD
Methyldopa—Asthenia—Metformin—metabolic syndrome X	0.000421	0.013	CcSEcCtD
Methyldopa—Epinephrine—TNF—metabolic syndrome X	0.000418	0.207	CrCbGaD
Methyldopa—Diarrhoea—Metformin—metabolic syndrome X	0.000401	0.0124	CcSEcCtD
Methyldopa—Dizziness—Metformin—metabolic syndrome X	0.000388	0.012	CcSEcCtD
Methyldopa—Vomiting—Metformin—metabolic syndrome X	0.000373	0.0115	CcSEcCtD
Methyldopa—Rash—Metformin—metabolic syndrome X	0.00037	0.0114	CcSEcCtD
Methyldopa—Dermatitis—Metformin—metabolic syndrome X	0.00037	0.0114	CcSEcCtD
Methyldopa—Headache—Metformin—metabolic syndrome X	0.000368	0.0114	CcSEcCtD
Methyldopa—Nausea—Metformin—metabolic syndrome X	0.000348	0.0108	CcSEcCtD
Methyldopa—Mesalazine—PTGS2—metabolic syndrome X	0.000345	0.171	CrCbGaD
Methyldopa—COMT—Biological oxidations—FMO3—metabolic syndrome X	0.00014	0.0356	CbGpPWpGaD
Methyldopa—COMT—Metapathway biotransformation—FMO3—metabolic syndrome X	0.000138	0.0351	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—NR1H3—metabolic syndrome X	0.000129	0.0326	CbGpPWpGaD
Methyldopa—COMT—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.000123	0.0313	CbGpPWpGaD
Methyldopa—ADRA2A—Monoamine GPCRs—HTR2C—metabolic syndrome X	8.55e-05	0.0217	CbGpPWpGaD
Methyldopa—COMT—Phase II conjugation—GGT1—metabolic syndrome X	8.24e-05	0.0209	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—HDAC3—metabolic syndrome X	8.2e-05	0.0208	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—GCK—metabolic syndrome X	7.79e-05	0.0198	CbGpPWpGaD
Methyldopa—ADRA2A—Integration of energy metabolism—MLXIPL—metabolic syndrome X	7.43e-05	0.0188	CbGpPWpGaD
Methyldopa—DDC—Dopaminergic Neurogenesis—TGFB1—metabolic syndrome X	7.39e-05	0.0187	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—MTNR1B—metabolic syndrome X	7.33e-05	0.0186	CbGpPWpGaD
Methyldopa—ADRA2A—Amine ligand-binding receptors—HTR2C—metabolic syndrome X	7.18e-05	0.0182	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—G6PC2—metabolic syndrome X	6.87e-05	0.0174	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—NAMPT—metabolic syndrome X	6.4e-05	0.0162	CbGpPWpGaD
Methyldopa—DDC—Amino acid and derivative metabolism—GOT2—metabolic syndrome X	5.86e-05	0.0149	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—SREBF1—metabolic syndrome X	5.71e-05	0.0145	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—GHRL—metabolic syndrome X	5.41e-05	0.0137	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—ADIPOQ—metabolic syndrome X	5.24e-05	0.0133	CbGpPWpGaD
Methyldopa—DDC—Amino acid and derivative metabolism—GOT1—metabolic syndrome X	5.06e-05	0.0128	CbGpPWpGaD
Methyldopa—COMT—Biological oxidations—GGT1—metabolic syndrome X	4.82e-05	0.0122	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—GCKR—metabolic syndrome X	4.71e-05	0.0119	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—NR3C1—metabolic syndrome X	4.48e-05	0.0114	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—SIRT1—metabolic syndrome X	4.13e-05	0.0105	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—GCK—metabolic syndrome X	3.74e-05	0.00948	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	3.49e-05	0.00885	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—PPARA—metabolic syndrome X	3.43e-05	0.0087	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—LEP—metabolic syndrome X	3.26e-05	0.00826	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—metabolic syndrome X	2.91e-05	0.00737	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—PPARG—metabolic syndrome X	2.84e-05	0.00719	CbGpPWpGaD
Methyldopa—DDC—Metabolism—FMO3—metabolic syndrome X	2.7e-05	0.00685	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—SERPINE1—metabolic syndrome X	2.55e-05	0.00648	CbGpPWpGaD
Methyldopa—DDC—Metabolism—EPHX2—metabolic syndrome X	2.41e-05	0.00611	CbGpPWpGaD
Methyldopa—DDC—Metabolism—MLXIPL—metabolic syndrome X	2.41e-05	0.00611	CbGpPWpGaD
Methyldopa—COMT—Metabolism—FMO3—metabolic syndrome X	2.4e-05	0.00608	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	2.39e-05	0.00606	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—MTNR1B—metabolic syndrome X	2.28e-05	0.00579	CbGpPWpGaD
Methyldopa—DDC—Metabolism—G6PC2—metabolic syndrome X	2.26e-05	0.00574	CbGpPWpGaD
Methyldopa—COMT—Metabolism—MLXIPL—metabolic syndrome X	2.14e-05	0.00542	CbGpPWpGaD
Methyldopa—COMT—Metabolism—EPHX2—metabolic syndrome X	2.14e-05	0.00542	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	2.12e-05	0.00537	CbGpPWpGaD
Methyldopa—ADRA2A—Regulation of insulin secretion—INS—metabolic syndrome X	2.11e-05	0.00536	CbGpPWpGaD
Methyldopa—COMT—Metabolism—G6PC2—metabolic syndrome X	2.01e-05	0.0051	CbGpPWpGaD
Methyldopa—DDC—Metabolism—FABP4—metabolic syndrome X	1.93e-05	0.00488	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—GCK—metabolic syndrome X	1.9e-05	0.00482	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—TNF—metabolic syndrome X	1.84e-05	0.00468	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—CETP—metabolic syndrome X	1.83e-05	0.00465	CbGpPWpGaD
Methyldopa—DDC—Metabolism—HSD11B1—metabolic syndrome X	1.83e-05	0.00463	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	1.81e-05	0.0046	CbGpPWpGaD
Methyldopa—COMT—Metabolism—FABP4—metabolic syndrome X	1.71e-05	0.00433	CbGpPWpGaD
Methyldopa—ADRA2A—Integration of energy metabolism—INS—metabolic syndrome X	1.66e-05	0.00422	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	1.65e-05	0.00418	CbGpPWpGaD
Methyldopa—DDC—Metabolism—G6PD—metabolic syndrome X	1.63e-05	0.00413	CbGpPWpGaD
Methyldopa—COMT—Metabolism—HSD11B1—metabolic syndrome X	1.62e-05	0.00411	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—CNR1—metabolic syndrome X	1.6e-05	0.00405	CbGpPWpGaD
Methyldopa—DDC—Metabolism—HDAC3—metabolic syndrome X	1.59e-05	0.00403	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GCKR—metabolic syndrome X	1.55e-05	0.00394	CbGpPWpGaD
Methyldopa—DDC—Metabolism—LPA—metabolic syndrome X	1.55e-05	0.00394	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet Aggregation (Plug Formation)—AKT1—metabolic syndrome X	1.53e-05	0.00388	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PLA2G6—metabolic syndrome X	1.5e-05	0.00381	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—ALB—metabolic syndrome X	1.5e-05	0.0038	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	1.49e-05	0.00377	CbGpPWpGaD
Methyldopa—DDC—Metabolism—APOA5—metabolic syndrome X	1.49e-05	0.00377	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	1.48e-05	0.00376	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	1.48e-05	0.00375	CbGpPWpGaD
Methyldopa—COMT—Metabolism—G6PD—metabolic syndrome X	1.44e-05	0.00366	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	1.41e-05	0.00358	CbGpPWpGaD
Methyldopa—COMT—Metabolism—HDAC3—metabolic syndrome X	1.41e-05	0.00358	CbGpPWpGaD
Methyldopa—DDC—Metabolism—TRIB3—metabolic syndrome X	1.38e-05	0.00351	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—MTNR1B—metabolic syndrome X	1.38e-05	0.0035	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GCKR—metabolic syndrome X	1.38e-05	0.00349	CbGpPWpGaD
Methyldopa—COMT—Metabolism—LPA—metabolic syndrome X	1.38e-05	0.00349	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—IGF2—metabolic syndrome X	1.37e-05	0.00348	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	1.34e-05	0.0034	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PLA2G6—metabolic syndrome X	1.33e-05	0.00338	CbGpPWpGaD
Methyldopa—COMT—Metabolism—APOA5—metabolic syndrome X	1.32e-05	0.00335	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—PLA2G4A—metabolic syndrome X	1.29e-05	0.00328	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	1.27e-05	0.00322	CbGpPWpGaD
Methyldopa—DDC—Metabolism—NAMPT—metabolic syndrome X	1.24e-05	0.00315	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—CCL5—metabolic syndrome X	1.24e-05	0.00314	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GCK—metabolic syndrome X	1.23e-05	0.00313	CbGpPWpGaD
Methyldopa—DDC—Metabolism—LIPC—metabolic syndrome X	1.23e-05	0.00313	CbGpPWpGaD
Methyldopa—COMT—Metabolism—TRIB3—metabolic syndrome X	1.23e-05	0.00311	CbGpPWpGaD
Methyldopa—DDC—Metabolism—APOC3—metabolic syndrome X	1.23e-05	0.00311	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—IL6—metabolic syndrome X	1.22e-05	0.00308	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	1.21e-05	0.00308	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—CD36—metabolic syndrome X	1.21e-05	0.00306	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CETP—metabolic syndrome X	1.19e-05	0.00302	CbGpPWpGaD
Methyldopa—DDC—Metabolism—SCARB1—metabolic syndrome X	1.14e-05	0.00289	CbGpPWpGaD
Methyldopa—DDC—Metabolism—SREBF1—metabolic syndrome X	1.11e-05	0.0028	CbGpPWpGaD
Methyldopa—COMT—Metabolism—NAMPT—metabolic syndrome X	1.1e-05	0.00279	CbGpPWpGaD
Methyldopa—COMT—Metabolism—LIPC—metabolic syndrome X	1.09e-05	0.00278	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GCK—metabolic syndrome X	1.09e-05	0.00278	CbGpPWpGaD
Methyldopa—COMT—Metabolism—APOC3—metabolic syndrome X	1.09e-05	0.00276	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—HTR2C—metabolic syndrome X	1.08e-05	0.00273	CbGpPWpGaD
Methyldopa—DDC—Metabolism—HMGCR—metabolic syndrome X	1.08e-05	0.00273	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GOT2—metabolic syndrome X	1.08e-05	0.00273	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CETP—metabolic syndrome X	1.06e-05	0.00268	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—APOA1—metabolic syndrome X	1.05e-05	0.00267	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—AGT—metabolic syndrome X	1.03e-05	0.00262	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	1.02e-05	0.0026	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—GHRL—metabolic syndrome X	1.02e-05	0.00259	CbGpPWpGaD
Methyldopa—COMT—Metabolism—SCARB1—metabolic syndrome X	1.01e-05	0.00256	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	9.83e-06	0.00249	CbGpPWpGaD
Methyldopa—COMT—Metabolism—SREBF1—metabolic syndrome X	9.82e-06	0.00249	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CNR1—metabolic syndrome X	9.66e-06	0.00245	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	9.61e-06	0.00244	CbGpPWpGaD
Methyldopa—DDC—Metabolism—SLC2A4—metabolic syndrome X	9.59e-06	0.00243	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ABCA1—metabolic syndrome X	9.59e-06	0.00243	CbGpPWpGaD
Methyldopa—COMT—Metabolism—HMGCR—metabolic syndrome X	9.55e-06	0.00242	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GOT2—metabolic syndrome X	9.55e-06	0.00242	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—FMO3—metabolic syndrome X	9.53e-06	0.00242	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GGT1—metabolic syndrome X	9.28e-06	0.00235	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GOT1—metabolic syndrome X	9.28e-06	0.00235	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—IGF1—metabolic syndrome X	8.8e-06	0.00223	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ABCA1—metabolic syndrome X	8.51e-06	0.00216	CbGpPWpGaD
Methyldopa—COMT—Metabolism—SLC2A4—metabolic syndrome X	8.51e-06	0.00216	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—EPHX2—metabolic syndrome X	8.5e-06	0.00216	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—MLXIPL—metabolic syndrome X	8.5e-06	0.00216	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—metabolic syndrome X	8.35e-06	0.00212	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—ALB—metabolic syndrome X	8.34e-06	0.00211	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GOT1—metabolic syndrome X	8.24e-06	0.00209	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GGT1—metabolic syndrome X	8.24e-06	0.00209	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	8.23e-06	0.00209	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—G6PC2—metabolic syndrome X	7.99e-06	0.00203	CbGpPWpGaD
Methyldopa—DDC—Metabolism—APOB—metabolic syndrome X	7.88e-06	0.002	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—MTNR1B—metabolic syndrome X	7.81e-06	0.00198	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PLA2G4A—metabolic syndrome X	7.66e-06	0.00194	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	7.61e-06	0.00193	CbGpPWpGaD
Methyldopa—DDC—Metabolism—LPL—metabolic syndrome X	7.52e-06	0.00191	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CCL5—metabolic syndrome X	7.49e-06	0.0019	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CD36—metabolic syndrome X	7.15e-06	0.00181	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—MTNR1B—metabolic syndrome X	7.09e-06	0.0018	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IGF2—metabolic syndrome X	7.06e-06	0.00179	CbGpPWpGaD
Methyldopa—COMT—Metabolism—APOB—metabolic syndrome X	7e-06	0.00177	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—APOB—metabolic syndrome X	6.86e-06	0.00174	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PLA2G4A—metabolic syndrome X	6.81e-06	0.00173	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—FABP4—metabolic syndrome X	6.79e-06	0.00172	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	6.77e-06	0.00172	CbGpPWpGaD
Methyldopa—COMT—Metabolism—LPL—metabolic syndrome X	6.68e-06	0.00169	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PLA2G4A—metabolic syndrome X	6.67e-06	0.00169	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PPARA—metabolic syndrome X	6.65e-06	0.00169	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—HSD11B1—metabolic syndrome X	6.44e-06	0.00163	CbGpPWpGaD
Methyldopa—DDC—Metabolism—AGT—metabolic syndrome X	6.44e-06	0.00163	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CD36—metabolic syndrome X	6.35e-06	0.00161	CbGpPWpGaD
Methyldopa—DDC—Metabolism—APOE—metabolic syndrome X	6.31e-06	0.0016	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—AGT—metabolic syndrome X	6.26e-06	0.00159	CbGpPWpGaD
Methyldopa—DDC—Metabolism—APOA1—metabolic syndrome X	6.23e-06	0.00158	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—CD36—metabolic syndrome X	6.22e-06	0.00158	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HTR2C—metabolic syndrome X	6.08e-06	0.00154	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PPARA—metabolic syndrome X	5.9e-06	0.0015	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—GHRL—metabolic syndrome X	5.77e-06	0.00146	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—G6PD—metabolic syndrome X	5.74e-06	0.00146	CbGpPWpGaD
Methyldopa—COMT—Metabolism—AGT—metabolic syndrome X	5.71e-06	0.00145	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—HDAC3—metabolic syndrome X	5.6e-06	0.00142	CbGpPWpGaD
Methyldopa—COMT—Metabolism—APOE—metabolic syndrome X	5.6e-06	0.00142	CbGpPWpGaD
Methyldopa—COMT—Metabolism—APOA1—metabolic syndrome X	5.53e-06	0.0014	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HTR2C—metabolic syndrome X	5.52e-06	0.0014	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PPARG—metabolic syndrome X	5.49e-06	0.00139	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GCKR—metabolic syndrome X	5.48e-06	0.00139	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—LPA—metabolic syndrome X	5.48e-06	0.00139	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CNR1—metabolic syndrome X	5.46e-06	0.00138	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—APOA1—metabolic syndrome X	5.43e-06	0.00138	CbGpPWpGaD
Methyldopa—DDC—Metabolism—INS—metabolic syndrome X	5.39e-06	0.00137	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PLA2G6—metabolic syndrome X	5.3e-06	0.00134	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—metabolic syndrome X	5.27e-06	0.00134	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—APOA5—metabolic syndrome X	5.25e-06	0.00133	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—GHRL—metabolic syndrome X	5.24e-06	0.00133	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CCL2—metabolic syndrome X	5.16e-06	0.00131	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CNR1—metabolic syndrome X	4.96e-06	0.00126	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ALB—metabolic syndrome X	4.94e-06	0.00125	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—TRIB3—metabolic syndrome X	4.88e-06	0.00124	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PPARG—metabolic syndrome X	4.88e-06	0.00124	CbGpPWpGaD
Methyldopa—COMT—Metabolism—INS—metabolic syndrome X	4.78e-06	0.00121	CbGpPWpGaD
Methyldopa—DDC—Metabolism—NOS3—metabolic syndrome X	4.72e-06	0.0012	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HDAC3—metabolic syndrome X	4.68e-06	0.00119	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IGF1—metabolic syndrome X	4.54e-06	0.00115	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ALB—metabolic syndrome X	4.39e-06	0.00111	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NAMPT—metabolic syndrome X	4.38e-06	0.00111	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—LIPC—metabolic syndrome X	4.35e-06	0.0011	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GCK—metabolic syndrome X	4.35e-06	0.0011	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—APOC3—metabolic syndrome X	4.32e-06	0.0011	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PTGS2—metabolic syndrome X	4.32e-06	0.0011	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—SERPINE1—metabolic syndrome X	4.31e-06	0.00109	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—ALB—metabolic syndrome X	4.3e-06	0.00109	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CCL5—metabolic syndrome X	4.23e-06	0.00107	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CETP—metabolic syndrome X	4.2e-06	0.00106	CbGpPWpGaD
Methyldopa—COMT—Metabolism—NOS3—metabolic syndrome X	4.19e-06	0.00106	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—MTNR1B—metabolic syndrome X	4.19e-06	0.00106	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—NOS3—metabolic syndrome X	4.11e-06	0.00104	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—RBP4—metabolic syndrome X	4.08e-06	0.00103	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TRIB3—metabolic syndrome X	4.08e-06	0.00103	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SCARB1—metabolic syndrome X	4.02e-06	0.00102	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SREBF1—metabolic syndrome X	3.9e-06	0.00099	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CCL5—metabolic syndrome X	3.84e-06	0.000975	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PTGS2—metabolic syndrome X	3.84e-06	0.000973	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	3.83e-06	0.000971	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GOT2—metabolic syndrome X	3.8e-06	0.000963	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—HMGCR—metabolic syndrome X	3.8e-06	0.000963	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	3.67e-06	0.00093	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—APOC3—metabolic syndrome X	3.61e-06	0.000917	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—AGT—metabolic syndrome X	3.54e-06	0.000898	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ABCA1—metabolic syndrome X	3.38e-06	0.000858	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SLC2A4—metabolic syndrome X	3.38e-06	0.000858	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GOT1—metabolic syndrome X	3.28e-06	0.000831	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GGT1—metabolic syndrome X	3.28e-06	0.000831	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HTR2C—metabolic syndrome X	3.26e-06	0.000827	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—AGT—metabolic syndrome X	3.21e-06	0.000815	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CYBA—metabolic syndrome X	3.16e-06	0.000801	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GHRL—metabolic syndrome X	3.09e-06	0.000784	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CNR1—metabolic syndrome X	2.93e-06	0.000743	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—APOB—metabolic syndrome X	2.78e-06	0.000705	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—TGFB1—metabolic syndrome X	2.72e-06	0.000689	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PLA2G4A—metabolic syndrome X	2.7e-06	0.000686	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—LPL—metabolic syndrome X	2.65e-06	0.000673	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CCL2—metabolic syndrome X	2.65e-06	0.000671	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CD36—metabolic syndrome X	2.52e-06	0.00064	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IGF2—metabolic syndrome X	2.39e-06	0.000607	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PPARA—metabolic syndrome X	2.34e-06	0.000595	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—APOB—metabolic syndrome X	2.32e-06	0.00059	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—AGT—metabolic syndrome X	2.27e-06	0.000576	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCL5—metabolic syndrome X	2.27e-06	0.000576	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	2.26e-06	0.000574	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—APOE—metabolic syndrome X	2.23e-06	0.000564	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—LPL—metabolic syndrome X	2.22e-06	0.000563	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—APOA1—metabolic syndrome X	2.2e-06	0.000558	CbGpPWpGaD
Methyldopa—DDC—Metabolism—AKT1—metabolic syndrome X	2.17e-06	0.000551	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PPARG—metabolic syndrome X	1.94e-06	0.000492	CbGpPWpGaD
Methyldopa—COMT—Metabolism—AKT1—metabolic syndrome X	1.93e-06	0.000489	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—INS—metabolic syndrome X	1.9e-06	0.000482	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	1.9e-06	0.000482	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	1.89e-06	0.000479	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	1.86e-06	0.000472	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	1.86e-06	0.000472	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	1.84e-06	0.000466	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ALB—metabolic syndrome X	1.74e-06	0.000442	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NOS3—metabolic syndrome X	1.67e-06	0.000423	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	1.66e-06	0.000421	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	1.59e-06	0.000403	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	1.56e-06	0.000397	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	1.54e-06	0.00039	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	1.52e-06	0.000387	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.46e-06	0.00037	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	1.39e-06	0.000354	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	1.19e-06	0.000303	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	1.18e-06	0.000298	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	1.08e-06	0.000275	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	9.22e-07	0.000234	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—AKT1—metabolic syndrome X	7.66e-07	0.000194	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	6.95e-07	0.000176	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	6.41e-07	0.000162	CbGpPWpGaD
